Click here to enlarge.
PDB ID:
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR31064
MolProbity Validation Chart
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Theophall, Gregory; Ramirez, Lisa; Premo, Aaron; Reverdatto, Sergey; Manigrasso, Michaele; Yepuri, Gautham; Burz, David; Ramasamy, Ravichandran; Schmidt, Ann Marie; Shekhtman, Alexander. "Disruption of the Productive Encounter Complex Results in Dysregulation of DIAPH1 Activity" J. Biol. Chem. 299, 105342-105342 (2023).
PubMed: 37832872
Assembly members:
entity_1, polymer, 256 residues, 29116.410 Da.
entity_2, polymer, 29 residues, 3161.510 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli
Entity Sequences (FASTA):
entity_1: MGSSERSHHHHHHSGSESKS
AMMYIQELRSGLRDMPLLSC
LESLRVSLNNNPVSWVQTFG
AEGLASLLDILKRLHDEKEE
TAGSYDSRNKHEIIRCLKAF
MNNKFGIKTMLETEEGILLL
VRAMDPAVPNMMIDAAKLLS
ALCILPQPEDMNERVLEAMT
ERAEMDEVERFQPLLDGLKS
GTTIALKVGCLQLINALITP
AEELDFRVHIRSELMRLGLH
QVLQDLREIENEDMRVQLNV
FDEQGEEDSYDLKGRL
entity_2: DETGVLDSLLEALQSGAAFR
RKRGPRQAN
Data type | Count |
13C chemical shifts | 463 |
15N chemical shifts | 253 |
1H chemical shifts | 1706 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | unit_1 | 1 |
2 | unit_2 | 2 |
Entity 1, unit_1 256 residues - 29116.410 Da.
1 | MET | GLY | SER | SER | GLU | ARG | SER | HIS | HIS | HIS | ||||
2 | HIS | HIS | HIS | SER | GLY | SER | GLU | SER | LYS | SER | ||||
3 | ALA | MET | MET | TYR | ILE | GLN | GLU | LEU | ARG | SER | ||||
4 | GLY | LEU | ARG | ASP | MET | PRO | LEU | LEU | SER | CYS | ||||
5 | LEU | GLU | SER | LEU | ARG | VAL | SER | LEU | ASN | ASN | ||||
6 | ASN | PRO | VAL | SER | TRP | VAL | GLN | THR | PHE | GLY | ||||
7 | ALA | GLU | GLY | LEU | ALA | SER | LEU | LEU | ASP | ILE | ||||
8 | LEU | LYS | ARG | LEU | HIS | ASP | GLU | LYS | GLU | GLU | ||||
9 | THR | ALA | GLY | SER | TYR | ASP | SER | ARG | ASN | LYS | ||||
10 | HIS | GLU | ILE | ILE | ARG | CYS | LEU | LYS | ALA | PHE | ||||
11 | MET | ASN | ASN | LYS | PHE | GLY | ILE | LYS | THR | MET | ||||
12 | LEU | GLU | THR | GLU | GLU | GLY | ILE | LEU | LEU | LEU | ||||
13 | VAL | ARG | ALA | MET | ASP | PRO | ALA | VAL | PRO | ASN | ||||
14 | MET | MET | ILE | ASP | ALA | ALA | LYS | LEU | LEU | SER | ||||
15 | ALA | LEU | CYS | ILE | LEU | PRO | GLN | PRO | GLU | ASP | ||||
16 | MET | ASN | GLU | ARG | VAL | LEU | GLU | ALA | MET | THR | ||||
17 | GLU | ARG | ALA | GLU | MET | ASP | GLU | VAL | GLU | ARG | ||||
18 | PHE | GLN | PRO | LEU | LEU | ASP | GLY | LEU | LYS | SER | ||||
19 | GLY | THR | THR | ILE | ALA | LEU | LYS | VAL | GLY | CYS | ||||
20 | LEU | GLN | LEU | ILE | ASN | ALA | LEU | ILE | THR | PRO | ||||
21 | ALA | GLU | GLU | LEU | ASP | PHE | ARG | VAL | HIS | ILE | ||||
22 | ARG | SER | GLU | LEU | MET | ARG | LEU | GLY | LEU | HIS | ||||
23 | GLN | VAL | LEU | GLN | ASP | LEU | ARG | GLU | ILE | GLU | ||||
24 | ASN | GLU | ASP | MET | ARG | VAL | GLN | LEU | ASN | VAL | ||||
25 | PHE | ASP | GLU | GLN | GLY | GLU | GLU | ASP | SER | TYR | ||||
26 | ASP | LEU | LYS | GLY | ARG | LEU |
Entity 2, unit_2 29 residues - 3161.510 Da.
1 | ASP | GLU | THR | GLY | VAL | LEU | ASP | SER | LEU | LEU | ||||
2 | GLU | ALA | LEU | GLN | SER | GLY | ALA | ALA | PHE | ARG | ||||
3 | ARG | LYS | ARG | GLY | PRO | ARG | GLN | ALA | ASN |
sample_1: Diaphanous inhibitory domain, [U-15N], 300 uM; Diaphanous autoregulatory domain 500 uM
sample_2: Diaphanous inhibitory domain, [U-15N], 300 uM; Diaphanous autoregulatory domain, [U-13C], 500 uM
sample_3: Diaphanous inhibitory domain, [U-100% 13C; U-100% 15N], 300 uM; Diaphanous autoregulatory domain 500 uM
sample_4: Diaphanous inhibitory domain 300 uM; Diaphanous autoregulatory domain, [U-100% 13C; U-100% 15N], 500 uM
sample_5: Diaphanous inhibitory domain 300 uM; Diaphanous autoregulatory domain, [U-100% 15N], 300 uM
sample_conditions_1: ionic strength: 140 mM; pH: 7.5; pressure: 1 atm; temperature: 305 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
3D CBCA(CO)NH | sample_3 | isotropic | sample_conditions_1 |
3D HNCO | sample_3 | isotropic | sample_conditions_1 |
3D HNCA | sample_3 | isotropic | sample_conditions_1 |
3D HNCACB | sample_3 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_3 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_1 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_5 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_2 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_1 | isotropic | sample_conditions_1 |
3D HNCA | sample_4 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_5 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_4 | isotropic | sample_conditions_1 |
3D HNCACB | sample_4 | isotropic | sample_conditions_1 |
3D H(CCO)NH | sample_3 | isotropic | sample_conditions_1 |
3D HBHA(CO)NH | sample_4 | isotropic | sample_conditions_1 |
H(CCH)-TOCSY | sample_4 | isotropic | sample_conditions_1 |
TopSpin, Bruker Biospin - collection, processing
CARA, Keller and Wuthrich - chemical shift assignment, peak picking
CYANA, Guntert, Mumenthaler and Wuthrich - structure calculation
YASARA, Krieger - refinement
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks